AISAP develops AI-enabled software for point-of-care ultrasound workflows.
Introduce me to AISAP
Image source: company website sharing image
Founders & company facts
Sources reviewed:Reported cumulative funding
$13,000,000 · Source
This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .
Documented founding team
- Adiel Am-ShalomSource: Adiel Am-Shalom
- Ehud RaananiSource: Ehud Raanani
- Robert KlempfnerSource: Robert Klempfner
- Founded
- 2022Source
- Reported Israeli location
- Ramat GanSource
- Team range in directory
- 11-50Source
- Reported business model
- B2BSource
Selected disclosed financing
Selected transactions, with dates, funding types and reported participants.
- May 2024$13MSeed
Company overview
Product & customers
AISAP develops AI-enabled software for point-of-care ultrasound workflows. Its platform supports image analysis, interpretation and reporting, connecting bedside examinations with the wider clinical care process.
Commercial potential · editorial analysis
The commercial opportunity is helping care teams use bedside ultrasound more consistently while reducing administrative steps between image capture and documented clinical review. Investors should distinguish paid use and renewals from pilots, and examine how sales and delivery costs change as deployments expand.
What to validate
Diligence should focus on cleared indications, validation across scanners and patient populations, clinician oversight and integration with medical records. Evidence should come from representative customer deployments, with costs, limitations and failure cases reported alongside successful results.
Product source reviewed on . Company source